The Food and Drug Administration (FDA) has released three draft guidelines aimed at reducing the transmission risk of hepatitis B (HBV), hepatitis C (HCV), and HIV through human cells and tissues. These guidelines update previous recommendations to help organizations determine donor eligibility through proper screening and testing. Comments on these drafts are encouraged by February 6, 2025, and can be submitted electronically or in writing. The drafts also advise on eliminating certain donor screening questions and focus on assessing each donor's risk based on relevant factors, regardless of gender.
Simple Explanation
The FDA has shared new ideas on how to keep people safe by checking and testing donations of human cells and tissues to make sure they don't pass on hepatitis B, hepatitis C, or HIV. They're asking everyone to tell them what they think about these ideas by February 6, 2025.